# What can you try before a procedure? *Joint Pain Relief Tempe — What Can You Try First?* > A plain joint pain relief Tempe guide to movement, medicine, sleep and the point when a sore joint needs a visit. ## Where do you start when a joint keeps aching? Tempe errands can mean several short walks across hot parking lots. Those small trips can add up for an aching joint. I’d begin by trimming the activity that makes tomorrow rough, then leave other routines alone. You don’t need to stop every useful movement. ## What helps without leaving home? Slowly bend a knee or hip, then straighten it; stop before the soreness grows. With a shoulder, lift and lower your arm only while the movement feels smooth. Shorten your walk, carry less, or split a large chore into smaller sessions. Heat may ease stiffness, while a cold pack can calm soreness after activity. ## Which medicines need extra care? A cream may help a joint close to the skin without sending as much medicine through your body. Pills may trouble the stomach or kidneys, affect the heart, or clash with drugs you already take. Ask your doctor or pharmacist which of those troubles applies to you. Acetaminophen helps some people, but it isn’t strong relief for every joint. ## Can sleep and pacing really help? Poor sleep can make soreness harder to bear the next day. Better sleep won’t mend joint wear, but it may leave you steadier for easy exercise. Pacing means stopping before one good day causes two bad ones. You’ll know the amount is close when the joint settles by tomorrow and lets you do ordinary tasks again. ## When has home care had enough time? Book your visit if lighter activity hasn’t begun to help by the end of the week, or sooner if the ache worsens. Useful movement means you can sleep, dress, walk through the house, and do basic chores. The doctor may check strength and motion, review an old X-ray, or order another test. An X-ray helps when it shows a change where you hurt and the exam brings on the same soreness; otherwise, the doctor keeps looking for another cause. ## Sources 1. A Cochrane overview of 21 systematic reviews (381 studies, 37,143 participants) covering rheumatoid arthritis, osteoarthritis, fibromyalgia, low back pain, neck disorder and other chronic pain conditions concluded that physical activity and exercise are interventions with few adverse events that may improve pain severity and physical function - but that the quality of the evidence is low, effects on pain were inconsistent across reviews, and physical function improved significantly in 14 reviews with only small-to-moderate effect sizes. The commonest reported adverse event was increased muscle soreness that settled within weeks. Geneen LJ, Moore RA, Clarke C, Martin D, Colvin LA, Smith BH — [Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews.](https://pubmed.ncbi.nlm.nih.gov/28436583/). *Cochrane Database of Systematic Reviews*, 2017. DOI: 10.1002/14651858.CD011279.pub3. 2. OARSI's 2019 guideline is the only major osteoarthritis guideline that grades treatments separately for people with disease in MULTIPLE joints. Its Core Treatments for polyarticular OA are arthritis education and structured land-based exercise. Critically, intra-articular corticosteroid and intra-articular hyaluronic acid were Level 1B/2 options for knee OA only and were NOT recommended for hip or polyarticular OA; oral NSAIDs were not recommended at all for people with cardiovascular comorbidity or frailty; and paracetamol/acetaminophen was conditionally not recommended. Bannuru RR, Osani MC, Vaysbrot EE, et al. — [OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.](https://pubmed.ncbi.nlm.nih.gov/31278997/). *Osteoarthritis and Cartilage*, 2019. DOI: 10.1016/j.joca.2019.06.011. 3. A network meta-analysis of 192 randomised trials in 102,829 patients with knee or hip osteoarthritis found that five oral preparations - diclofenac 150 mg/day, etoricoxib 60 and 90 mg/day, and rofecoxib 25 and 50 mg/day - had a 99% or greater probability of exceeding the minimal clinically important reduction in pain. Topical diclofenac (70-81 and 140-160 mg/day) had a 92.3% or greater probability. Every opioid studied had a 53% or LOWER probability of exceeding that threshold. da Costa BR, Pereira TV, Saadat P, et al. — [Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/34642179/). *BMJ*, 2021. DOI: 10.1136/bmj.n2321. 4. A Cochrane review of 75 studies in 9,401 adults with chronic pain found cognitive behavioural therapy produced small benefits over treatment as usual at the end of treatment - pain SMD -0.22 (95% CI -0.33 to -0.10), disability SMD -0.32 (-0.45 to -0.19), distress SMD -0.34 (-0.44 to -0.24) - and very small benefits over an active control. Effects were largely maintained at follow-up against treatment as usual but not against active control. Evidence for behavioural therapy and acceptance and commitment therapy was moderate to very low certainty. Williams ACdC, Fisher E, Hearn L, Eccleston C — [Psychological therapies for the management of chronic pain (excluding headache) in adults.](https://pubmed.ncbi.nlm.nih.gov/32794606/). *Cochrane Database of Systematic Reviews*, 2020. DOI: 10.1002/14651858.CD007407.pub4. 5. A systematic review and dose-response meta-analysis of 11 randomised trials in 1,801 people with chronic musculoskeletal pain found cognitive behavioural therapy for insomnia produced a large effect on insomnia (SMD -1.34, 95% CI -2.12 to -0.56), peaking at about 450 minutes of therapy, with a large effect already at 250 minutes. The effect on pain intensity itself was not significant. Salazar-Mendez J, Viscay-Sanhueza N, Pinto-Vera C, et al. — [Cognitive behavioral therapy for insomnia in people with chronic musculoskeletal pain. A systematic review and dose-response meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/39111059/). *Sleep Medicine*, 2024. DOI: 10.1016/j.sleep.2024.07.031. 6. A meta-analysis of 13 randomised trials in 4,201 participants across four countries found duloxetine statistically superior to placebo for 24-hour average pain, quality of life, physical function and global impression in chronic musculoskeletal pain, with no difference in serious adverse events. Ma X, Zhou S, Sun L, et al. — [Efficacy and safety of duloxetine in chronic musculoskeletal pain: a systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/37198620/). *BMC Musculoskeletal Disorders*, 2023. DOI: 10.1186/s12891-023-06488-6. 7. A meta-analysis of 20 dietary supplements across 69 randomised trials in hand, hip or knee osteoarthritis found that seven (collagen hydrolysate, passion fruit peel extract, Curcuma longa extract, Boswellia serrata extract, curcumin, pycnogenol and L-carnitine) showed large short-term effects on pain, and six more (undenatured type II collagen, avocado soybean unsaponifiables, methylsulfonylmethane, diacerein, glucosamine, chondroitin) showed statistically significant but clinically unclear effects. At MEDIUM term only green-lipped mussel extract and undenatured type II collagen retained clinically important effects, and NO supplement had a clinically important effect on pain at long term. Liu X, Machado GC, Eyles JP, Ravi V, Hunter DJ — [Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/29018060/). *British Journal of Sports Medicine*, 2018. DOI: 10.1136/bjsports-2016-097333. 8. Within the VITAL trial - 25,871 US adults randomised in a 2-by-2 factorial design to vitamin D and/or marine omega-3 fatty acids - a subgroup of 1,398 participants with pre-existing chronic knee pain (mean age 67.7, 66% women, mean WOMAC pain 37 of 100) was followed for a mean of 5.3 years. WOMAC pain did not differ between active vitamin D and its placebo, or between active omega-3 and its placebo, at any time point, and the time-by-treatment interactions were not significant. Function and stiffness gave the same answer. MacFarlane LA, Cook NR, Kim E, et al. — [The Effects of Vitamin D and Marine Omega-3 Fatty Acid Supplementation on Chronic Knee Pain in Older US Adults: Results From a Randomized Trial.](https://pubmed.ncbi.nlm.nih.gov/32583982/). *Arthritis & Rheumatology*, 2020. DOI: 10.1002/art.41416. 9. An updated individual patient data meta-analysis pooled 39 trials and 20,827 patients with non-specific musculoskeletal pain, osteoarthritis, chronic headache or shoulder pain, restricted to trials with unambiguously adequate allocation concealment. Acupuncture was superior both to sham and to no-acupuncture control for every condition (all p<0.001), with differences of about 0.5 standard deviations versus no acupuncture and about 0.2 standard deviations versus sham. Effects persisted with only about a 15% decrease at one year. Vickers AJ, Vertosick EA, Lewith G, et al. — [Acupuncture for Chronic Pain: Update of an Individual Patient Data Meta-Analysis.](https://pubmed.ncbi.nlm.nih.gov/29198932/). *The Journal of Pain*, 2018. DOI: 10.1016/j.jpain.2017.11.005. 10. FDA states verbatim that of the products marketed as regenerative medicine - stem cell products, stromal vascular fraction from adipose tissue, umbilical cord blood, Wharton's jelly, amniotic fluid and exosome products - 'None of these products have been approved for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' The only FDA-approved stem cell products in the United States are blood-forming (hematopoietic progenitor) cells from umbilical cord blood, approved only for disorders of blood production, and there are currently no FDA-approved exosome products. U.S. Food and Drug Administration — [Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes). *FDA (Center for Biologics Evaluation and Research)*, 2024. ## What if the soreness keeps getting in your way? Note when the ache started, the motions that hurt, and what helped at home. Ask what the exam suggests, what isn’t known, and which non-surgical choices may fit. Book a free consultation: --- Why it aches, what may help, and when to call. Clear Tempe answers about aching joints, likely causes, simple home steps, urgent changes, and nearby care. Plain Tempe answers about sore joints, care at home, warning signs, and nearby visits. This website is run by the same owners who operate QC Kinetix clinics across the Phoenix area; their clinic business may benefit when a visitor books a consultation. © 2026 The Tempe Relief Ledger. General education only; personal symptoms and treatment choices belong in a conversation with a qualified clinician.